Register to receive a free US Market Report Suite for Gastrointestinal Endoscopic Devices 2017 – MedSuite report synopsis and brochure
Olympus recently announced the expansion of its EndoTherapy product line, building on the company’s commitment to innovation and advancement in the field of endoscopy and its history as a pioneer in Endoscopic Submucosal Dissection (ESD).
The 3-in-1 SB Knives™ enable mucosal incision, submucosal dissection and hemostasis, for controlled, precision cutting. The SB Knives are a line of scissor-type ESD knives available in the U.S. through an exclusive distribution agreement between Olympus and Sumitomo Bakelite Co., Ltd. SB Knives are used in ESD to remove early gastrointestinal cancers that have not entered the muscle layer. Minimally invasive ESD procedures can sometimes help patients avoid open surgery. These knives further emphasize Olympus’ status as an ESD champion, building on its influence in the early development of ESD as a practice, which was first identified as a procedure separate from endoscopic mucosal resection in 2003.
Olympus announced its co-promotion agreement of Eleview™ in the U.S. with Aries Pharmaceuticals. Eleview, designed for easy and safe resection, increases visibility of target lesion margins and is designed to lower the risk of perforation. Eleview improves margin visualization to help decrease the risk of gastrointestinal perforation and damage to the external muscular layer, which can lead to gastrointestinal perforation and may decrease the time needed to resect a lesion while reducing both reinjections required and piecemeal excisions, as compared to saline. Eleview was developed by Cosmo Pharmaceuticals N.V. Olympus and Aries, the U.S. distribution arm of Aries Ltd. and a wholly owned subsidiary of Cosmo, will work together to promote Eleview to end-user customers and will each sell the product through their existing distribution networks. This combined effort will leverage both company’s established salesforce and distribution networks to address the colonoscopy market in an efficient and cost-effective manner.
Additionally, Olympus announced its exclusive distribution agreement with Ruhof Healthcare for Guardian Endoscope Single-Use Valve Set, a sterile, disposable valve that eliminates the need for manual cleaning. Manufactured by Ruhof, Guardian Endoscope Single-Use Valve Set will be distributed in the U.S. by the Olympus Endoscopy Sales team. Designed for use in Olympus 140/160/180/190 Series Endoscopes, Guardian Endoscope Single-Use Valve Set is color coded for easy identification and differentiation. Each set contains one air/water, suction and biopsy valve and helps to prevent cross contamination. Through this partnership, Ruhof and Olympus are helping to create consistent practices and reduce the potential for error and healthcare-associated infections.
“With each device we unveil to the GI community, Olympus gains strength as being more than an excellent imaging partner; we evolve into a complete solutions provider to our customers,” said Kurt Heine Group Vice President, Endoscopy Division at Olympus America Inc. “Strategic partnerships, a commitment to innovation and a drive to provide methods to raise quality and satisfaction while lowering costs – these are ways we build trust with our customers every day.”
The SB Knives and these agreements will be highlighted to the healthcare community at the American College of Gastroenterology’s (ACG) World Congress of Gastroenterology conference in Orlando, October 13-18.
To learn more about these products, please call 1-800-848-9024 or visit us at http://medical.olympusamerica.com.
For Further Information
More on the GI endoscopy market in the U.S. can be found in a series of reports published by iData Research entitled the US Market Report Suite for Gastrointestinal Endoscopic Devices 2017 – MedSuite. The suite covers reports on the following markets: GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus.
The iData report series on GI endoscopic devices covers the U.S. and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about GI market data or procedure data, register online or email us at [email protected] for a US Market Report Suite for Gastrointestinal Endoscopic Devices 2017 – MedSuite brochure and synopsis.